0001062993-20-006257.txt : 20201211
0001062993-20-006257.hdr.sgml : 20201211
20201211165531
ACCESSION NUMBER: 0001062993-20-006257
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Edward F
CENTRAL INDEX KEY: 0001368350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39267
FILM NUMBER: 201384099
MAIL ADDRESS:
STREET 1: C/O POLYMEDIX, INC.
STREET 2: 3701 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Benitec Biopharma Inc.
CENTRAL INDEX KEY: 0001808898
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
BUSINESS PHONE: 61(0)3 8692-7222
MAIL ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-12-09
0001808898
Benitec Biopharma Inc.
BNTC
0001368350
Smith Edward F
C/O BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD
CA
94545
1
0
0
0
Options (right to buy)
2.98
2020-12-09
4
A
0
23601
0
A
2030-12-09
Common Stock
23601
23601
D
The stock options will vest in three substantially equal installments on the day prior to each of the Issuer???s next three annual stockholder meetings occurring immediately following the date of grant.
/s/ Edward Smith
2020-12-11